VIDA Diagnostics And Olympus Expand Strategic Partnership
SAN FRANCISCO, May 16, 2016 /PRNewswire/ -- VIDA Diagnostics, Inc. ("VIDA"), the leader in precision pulmonary imaging, announced an expanded collaboration with Olympus Respiratory America, a leading developer of devices for the treatment of acute and chronic conditions of the lung and a subsidiary of Olympus Corporation, at the 2016 American Thoracic Society Meeting. Under the agreement, VIDA and Olympus will incorporate precision informatics into current and future diagnostic and therapeutic procedural workflows to manage patients with pulmonary diseases.
"Olympus' goals are to develop more comprehensive technologies and tools to localize, diagnose and treat the small pulmonary nodule," said Katsuyuki Saito, Executive Officer, Olympus Corporation. "By unifying advanced procedural selection and planning techniques using VIDA, we aim to offer a high value, efficient solution for the physician and patient."
The collaboration covers North America and Europe and will include marketing and development programs in interventional pulmonology, tightly integrating imaging informatics software and services to drive diagnostic and therapeutic procedures.
"Precision medicine requires precision information and we are delighted to expand our partnership with Olympus to advance interventional pulmonology," said Susan A. Wood, Ph.D., President and CEO of VIDA. "The partnership enables integrated and streamlined procedural workflows, essential for higher-value precision care and builds on the successes of our Olympus partnership to date."
About VIDA
VIDA is focused on changing the practice of pulmonary care by empowering the pulmonary clinician with precision informatics. VIDA's suite of software and associated analysis services aid early detection, evaluation, and treatment planning of lung diseases, including lung cancer, emphysema, airway obstruction diseases, and asthma. VIDA's software and services are cleared for clinical use in the United States, Canada, European Union, and Australia. VIDA is headquartered in Coralville, IA, with an additional office in Minneapolis, MN. For more information, contact VIDA at marketing@vidadiagnostics.com.
About Olympus Respiratory America and Olympus
Olympus Respiratory America, a subsidiary of Olympus Corporation, is committed to helping physicians improve the quality of life for patients with acute and chronic conditions of the lung. Olympus is a global medical device and optical technology leader focused on contributing to society by making people's lives healthier, safer and more fulfilling around the world. Olympus researches, develops, manufactures, markets and services innovative solutions in its core business areas of Medical and Surgical Products, Scientific Solutions, and Cameras and Audio Recorders. Olympus Corporation is headquartered in Tokyo, Japan. For more information, visit Olympus at www.olympus-global.com.
Logo - http://photos.prnewswire.com/prnh/20160104/319103LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vida-and-olympus-expand-strategic-partnership-300269176.html
SOURCE VIDA Diagnostics, Inc.
